Cargando…

Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches

The constant changes in cancer cell bioenergetics are widely known as metabolic reprogramming. Reprogramming is a process mediated by multiple factors, including oncogenes, growth factors, hypoxia-induced factors, and the loss of suppressor gene function, which support malignant transformation and t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Navarro, Carla, Ortega, Ángel, Santeliz, Raquel, Garrido, Bermary, Chacín, Maricarmen, Galban, Néstor, Vera, Ivana, De Sanctis, Juan Bautista, Bermúdez, Valmore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9227908/ https://www.ncbi.nlm.nih.gov/pubmed/35745875 http://dx.doi.org/10.3390/pharmaceutics14061303

Ejemplares similares

Intrinsic and environmental basis of aging: A narrative review
por: Navarro, Carla, et al.
Publicado: (2023)

Specialized Proresolving Lipid Mediators: A Potential Therapeutic Target for Atherosclerosis
por: Salazar, Juan, et al.
Publicado: (2022)

Exploring the Relationship between the Gut Microbiota and Ageing: A Possible Age Modulator
por: Salazar, Juan, et al.
Publicado: (2023)

The YAP/TAZ Signaling Pathway in the Tumor Microenvironment and Carcinogenesis: Current Knowledge and Therapeutic Promises
por: Ortega, Ángel, et al.
Publicado: (2021)

Advanced Glycation End Products: New Clinical and Molecular Perspectives
por: Salazar, Juan, et al.
Publicado: (2021)

Neprilysin: A Potential Therapeutic Target of Arterial Hypertension?
por: Salazar, Juan, et al.
Publicado: (2020)

Specialized Pro-Resolving Lipid Mediators: The Future of Chronic Pain Therapy?
por: Chávez-Castillo, Mervin, et al.
Publicado: (2021)

Cigarette smoking and metabolic syndrome components: a cross-sectional study from Maracaibo City, Venezuela
por: Bermudez, Valmore, et al.
Publicado: (2019)

Low Doses of Melatonin to Improve Sleep in Children with ADHD: An Open-Label Trial
por: Checa-Ros, Ana, et al.
Publicado: (2023)

Microbiota and Diabetes Mellitus: Role of Lipid Mediators
por: Salazar, Juan, et al.
Publicado: (2020)

Lipid Accumulation Product Is More Related to Insulin Resistance than the Visceral Adiposity Index in the Maracaibo City Population, Venezuela
por: Bermúdez, Valmore, et al.
Publicado: (2021)

Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association
por: Bermúdez, Valmore, et al.
Publicado: (2018)

Role of Endocrine-Disrupting Chemicals in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: A Comprehensive Review
por: Cano, Raquel, et al.
Publicado: (2021)

Psycho-Neuro-Endocrine-Immunological Basis of the Placebo Effect: Potential Applications beyond Pain Therapy
por: Ortega, Ángel, et al.
Publicado: (2022)

C-Reactive Protein: An In-Depth Look into Structure, Function, and Regulation
por: Salazar, Juan, et al.
Publicado: (2014)

Metabolic Syndrome: Is It Time to Add the Central Nervous System?
por: Rojas, Milagros, et al.
Publicado: (2021)

Sensitivity and Specificity Improvement in Abdominal Obesity Diagnosis Using Cluster Analysis during Waist Circumference Cut-Off Point Selection
por: Bermúdez, Valmore, et al.
Publicado: (2015)

Exploring the Links between Obesity and Psoriasis: A Comprehensive Review
por: Barros, Gabriela, et al.
Publicado: (2022)

Depression as a Neuroendocrine Disorder: Emerging Neuropsychopharmacological Approaches beyond Monoamines
por: Chávez-Castillo, Mervin, et al.
Publicado: (2019)

The Sick Adipose Tissue: New Insights Into Defective Signaling and Crosstalk With the Myocardium
por: Bermúdez, Valmore, et al.
Publicado: (2021)

Metabolic reprogramming: the emerging concept and associated therapeutic strategies
por: Yoshida, Go J.
Publicado: (2015)

Epidemiologic Behavior and Estimation of an Optimal Cut-Off Point for Homeostasis Model Assessment-2 Insulin Resistance: A Report from a Venezuelan Population
por: Bermúdez, Valmore, et al.
Publicado: (2014)

The Role of the α Cell in the Pathogenesis of Diabetes: A World beyond the Mirror
por: Martínez, María Sofía, et al.
Publicado: (2021)

The Role of Specialized Pro-Resolving Lipid Mediators in Inflammation-Induced Carcinogenesis
por: Torres, Wheeler, et al.
Publicado: (2023)

Electroconvulsive Therapy in Psychiatric Disorders: A Narrative Review Exploring Neuroendocrine–Immune Therapeutic Mechanisms and Clinical Implications
por: Rojas, Milagros, et al.
Publicado: (2022)

Variations of Lipoprotein(a) Levels in the Metabolic Syndrome: A Report from the Maracaibo City Metabolic Syndrome Prevalence Study
por: Bermúdez, Valmore, et al.
Publicado: (2013)

Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
por: Rojas, Milagros, et al.
Publicado: (2021)

Metabolic reprogramming in cancer: Mechanisms and therapeutics
por: Nong, Shiqi, et al.
Publicado: (2023)

Mutant Kras copy number defines metabolic reprogramming and therapeutic susceptibilities
por: Kerr, Emma, et al.
Publicado: (2016)

The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus
por: Rojas, Joselyn, et al.
Publicado: (2014)

Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016)

Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma
por: Nguyen, Trang T. T., et al.
Publicado: (2022)

Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma
por: Pang, Yuyang, et al.
Publicado: (2023)

Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
por: Lasorsa, Francesco, et al.
Publicado: (2023)

Epicardial Fat: Physiological, Pathological, and Therapeutic Implications
por: Salazar, Juan, et al.
Publicado: (2016)

Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease
por: Chávez-Castillo, Mervin, et al.
Publicado: (2020)

Metabolic Reprogramming in Thyroid Carcinoma
por: Coelho, Raquel Guimaraes, et al.
Publicado: (2018)

Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
por: Gandhi, Nishant, et al.
Publicado: (2019)

Photoreceptor metabolic reprogramming: current understanding and therapeutic implications
por: Pan, Warren W., et al.
Publicado: (2021)

Metabolic Reprogramming in Kidney Diseases: Evidence and Therapeutic Opportunities
por: Li, Yin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_n4ini96pe9uk6b7ak1n8hq5usk